Radius Health

RDUS NASDAQ
22.51
+0.60
+2.74%
After Hours: 22.51 0 0.00% 17:53 07/17 EDT
Open
21.85
Prev Close
21.91
High
22.74
Low
21.65
Volume
300.54K
Avg Vol (3M)
493.70K
52 Week High
29.07
52 Week Low
12.81
% Turnover
0.65%
Market Cap
1.04B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Radius Health RDUS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Radius Health, Inc. is a biopharmaceutical company. The Company is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The Company's lead investigational product candidate, TYMLOS (abaloparatide-SC) injection is developed for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Company’s clinical pipeline also includes an investigational abaloparatide transdermal patch for potential use in osteoporosis and the investigational drug elacestrant (RAD1901) for potential use in hormone-driven and/or hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its RAD140 is a non-steroidal, selective androgen receptor modulator (SARM). RAD140 is under development for potential use in hormone receptor positive breast cancer.
MORE >

Recently

Name
Price
%Change